Insider Transactions Reported by 14 Insiders of Protalix BioTherapeutics, Inc.

Symbol
PLX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
2 University Plaza, Suite 100, Hackensack, NJ

Insiders trading volume in the past year

Protalix BioTherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dexcel Pharma Technologies Ltd. 10%+ Owner $5.13M Jun 2, 2021
Dror Bashan PRESIDENT AND CEO, Director $3.99M Sep 3, 2025
Eyal Rubin Sr. VP and CFO $932K Sep 23, 2024
Aharon Schwartz Director $500K +$206K +70% Sep 3, 2025
Yaron Naos Sr. VP, Operations $375K Sep 3, 2025
Yael Hayon VP, Research & Development $49.5K Aug 15, 2023
Amos Bar-Shalev Director $17K -$314 -1.82% Nov 18, 2025
Christian Elze Director $12.1K Sep 3, 2025
Pol F. Boudes Director $12.1K Sep 3, 2025
Gwen A. Melincoff Director $12.1K Sep 3, 2025
Zvi Shmuel Ben Director $12.1K Sep 3, 2025
Eliot Forster Director $12.1K Sep 3, 2025
Gilad Mamlok Sr. VP and CFO Aug 24, 2025
Zeev Bronfeld Director Sep 7, 2022

Recent Insider Transactions by Companies or Individuals for Protalix BioTherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.